Free Trial

Centessa Pharmaceuticals (CNTA) SEC Filings & 10K Form

Centessa Pharmaceuticals logo
$16.74 -0.09 (-0.53%)
(As of 11/20/2024 ET)

Recent Centessa Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:43 PM
Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:16 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2024
6:19 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:27 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:07 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:15 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q/A
09/27/2024
3:15 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:01 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
3:55 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
7:01 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:40 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
09/11/2024
3:01 PM
Centessa Pharmaceuticals (Filer)
Form S-3ASR
09/10/2024
3:04 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:06 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
6:08 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:06 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:12 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:13 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:19 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
4:15 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:32 PM
Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:13 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:38 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:52 PM
Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
6:27 AM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
6:15 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:31 PM
Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:30 PM
Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:31 PM
Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:32 PM
Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:33 PM
Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:34 PM
Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:34 PM
Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:14 PM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…

06/17/2024
7:49 PM
Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2024
6:13 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
7:48 PM
Centessa Pharmaceuticals (Filer)
Form DEFA14A
05/13/2024
3:32 PM
Centessa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:00 AM
Centessa Pharmaceuticals (Filer)
Form DEF 14A
05/09/2024
7:01 AM
Centessa Pharmaceuticals (Filer)
Form ARS
04/24/2024
7:53 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
04/24/2024
8:26 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
4:16 PM
Centessa Pharmaceuticals (Filer)
Form 424B5
04/22/2024
6:15 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:17 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:16 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:44 PM
Centessa Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
3:16 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:06 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
4:37 PM
Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
02/09/2024
6:12 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
4:10 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:02 PM
Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:03 PM
Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:04 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:07 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:08 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:09 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
6:56 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
6:56 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
6:41 PM
Centessa Pharmaceuticals (Issuer)
GRAINGER DAVID J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:43 PM
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:44 PM
Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:45 PM
Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:46 PM
Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:37 PM
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
6:05 AM
Centessa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CNTA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners